ArticlePreventive medicine reports2026
All-cause health-adjusted life expectancy in Jiangxi Province, China, 2000-2030: systematic estimation and analysis.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Using Jiangxi Province as a case study, this research aims to evaluate the progress in achieving the national "Healthy China 2030" all-cause health-adjusted life expectancy (HALE) targets at the subnational level. Methods: Based on provincial data collected between 2000 and 2020, we applied a simplified, validated model to estimate all-cause years lived with disability (YLD) rates. HALE was then calculated using the Sullivan method with provincial abridged life tables. Values for 2021-2030 were projected using the Lee-Carter and Autoregressive Integrated Moving Average (ARIMA) models. Missing data were handled via spline interpolation, and uncertainty was quantified via Monte Carlo simulation. Results: All-cause HALE in Jiangxi increased by 7.8 years from 2000 to 2020 and is projected to reach 71.6 years by 2030, meeting the national target despite a recent slowdown in growth. YLD rates declined in younger age groups but rose among those aged ≥80 years. Women consistently showed higher life expectancy and HALE than men, but accumulated more unhealthy life-years. Conclusions: Jiangxi Province is on track to achieve the "Healthy China 2030" HALE target. Persistent age and gender disparities highlight the need for tailored interventions-particularly for women and the growing elderly population-to improve health-related quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.